Copyright Reports & Markets. All rights reserved.

Toxicology Services Global Market – Forecast To 2025

Buy now

1 EXECUTIVE SUMMARY 25

    2 INTRODUCTION 29

    • 2.1 KEY TAKEAWAYS 29
    • 2.2 REPORT DESCRIPTION 29
    • 2.3 MARKETS COVERED 31
    • 2.4 STAKEHOLDERS 33
    • 2.5 RESEARCH METHODOLOGY 33
      • 2.5.1 MARKET SIZE ESTIMATION 35
      • 2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 37
      • 2.5.3 SECONDARY SOURCES 38
      • 2.5.4 PRIMARY SOURCES 38
      • 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 39
      • 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 39
      • 2.5.7 ASSUMPTIONS 40

    3 MARKET ANALYSIS 41

    • 3.1 INTRODUCTION 41
    • 3.2 MARKET SEGMENTATION 43
    • 3.3 FACTORS INFLUENCING MARKET 44
      • 3.3.1 DRIVERS AND OPPORTUNITIES 45
        • 3.3.1.1 Mandatory toxicology testing in various industries & rise in global R&D investments 45
        • 3.3.1.2 Increasing outsourcing trend 45
        • 3.3.1.3 Increased funding by the public and private sector 46
        • 3.3.1.4 Crop protection demand driven by the ongoing need to increase the efficiency of food production to feed growing global populations 47
        • 3.3.1.5 Rapid advances in technologies 48
        • 3.3.1.6 Increasing product failure due to safety concerns 48
      • 3.3.2 RESTRAINTS AND THREATS 49
        • 3.3.2.1 High cost and long duration of tests 49
        • 3.3.2.2 High capital and technical requirements for glp certification 50
        • 3.3.2.3 Increased funding towards repurposing 50
        • 3.3.2.4 Opposition to animal testing 51
        • 3.3.2.5 Limited ip protection in developing regions 51
    • 3.4 REGULATORY AFFAIRS 52
      • 3.4.1 INTRODUCTION 52
      • 3.4.2 PHARMACEUTICALS 52
      • 3.4.3 MEDICAL DEVICES 53
      • 3.4.4 COSMETICS 57
      • 3.4.5 CHEMICAL 58
        • 3.4.5.1 Industrial chemical 58
        • 3.4.5.2 Agrochemical, environmental and consumer goods 59
      • 3.4.6 FOOD 61
    • 3.5 MARKET SHARE ANALYSIS 62

    4 TOXICOLOGY SERVICES GLOBAL MARKET, BY METHOD 64

    • 4.1 INTRODUCTION 64
    • 4.2 IN VIVO TOXICOLOGY 67
    • 4.3 IN VITRO TOXICOLOGY 74
      • 4.3.1 CELLULAR & BIOCHEMICAL 80
      • 4.3.2 EX VIVO 83
      • 4.3.3 IN SILICO 86

    5 TOXICOLOGY SERVICES GLOBAL MARKET, BY INDUSTRY 89

    • 5.1 INTRODUCTION 89
    • 5.2 PHARMACEUTICAL 92
      • 5.2.1 DISCOVERY TOXICOLOGY 96
      • 5.2.2 PRECLINICAL TOXICOLOGY 96
    • 5.3 MEDICAL DEVICES 98
    • 5.4 COSMETICS 103
    • 5.5 CHEMICAL 109
      • 5.5.1 INDUSTRIAL CHEMICALS 115
      • 5.5.2 AGROCHEMICALS 120
      • 5.5.3 EVIRONMENTAL 125
    • 5.6 OTHER INDUSTRIES 128
      • 5.6.1 FOOD 133
      • 5.6.2 CONSUMER GOODS 139

    6 TOXICOLOGY SERVICES GLOBAL MARKET, BY ENDPOINT TESTS 142

    • 6.1 INTRODUCTION 142
    • 6.2 SYSTEMIC TOXICOLOGY 146
    • 6.3 ORGAN TOXICOLOGY 149
    • 6.4 DERMAL TOXICOLOGY 152
    • 6.5 NEUROTOXICOLOGY 156
    • 6.6 OCULAR TOXICOLOGY 159
    • 6.7 GENOTOXICOLOGY 162
    • 6.8 DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY 165
    • 6.9 CARCINOGENICITY 168
    • 6.10 ECOTOXICOLOGY 171

    7 TOXICOLOGY SERVICES MARKET, BY REGION 174

    • 7.1 INTRODUCTION 174
    • 7.2 NORTH AMERICA 176
      • 7.2.1 U.S. 189
      • 7.2.2 OTHERS 191
    • 7.3 EUROPE 193
      • 7.3.1 GERMANY 205
      • 7.3.2 FRANCE 207
      • 7.3.3 U.K. 209
      • 7.3.4 OTHERS 211
    • 7.4 ASIA-PACIFIC 213
      • 7.4.1 CHINA 225
      • 7.4.2 INDIA 227
      • 7.4.3 JAPAN 230
      • 7.4.4 OTHERS 232
    • 7.5 ROW 234
      • 7.5.1 BRAZIL 246
      • 7.5.2 REST OF LATIN AMERICA 248
      • 7.5.3 MIDDLE EAST & OTHERS 251

    8 COMPANY DEVELOPMENTS 254

    • 8.1 INTRODUCTION 254
    • 8.2 ACQUISITIONS & MERGERS 255
    • 8.3 AGREEMENTS & PARTNERSHIPS 257
    • 8.4 NEW SERVICE LAUNCH 259
    • 8.5 OTHERS 261

    9 MAJOR COMPANIES 272

    • 9.1 BUREAU VERITAS 272
      • 9.1.1 OVERVIEW 272
      • 9.1.2 FINANCIALS 273
      • 9.1.3 SERVICE PORTFOLIO 275
      • 9.1.4 KEY DEVELOPMENTS 276
      • 9.1.5 BUSINESS STRATEGY 276
      • 9.1.6 SWOT ANALYSIS 277
    • 9.2 CHARLES RIVER LABORATORIES 278
      • 9.2.1 OVERVIEW 278
      • 9.2.2 FINANCIALS 280
      • 9.2.3 SERVICE PORTFOLIO 283
      • 9.2.4 KEY DEVELOPMENTS 283
      • 9.2.5 BUSINESS STRATEGY 285
      • 9.2.6 SWOT ANALYSIS 286
    • 9.3 EUROFINS SCIENTIFIC 287
      • 9.3.1 OVERVIEW 287
      • 9.3.2 FINANCIALS 289
      • 9.3.3 SERVICE PORTFOLIO 291
      • 9.3.4 KEY DEVELOPMENTS 292
      • 9.3.5 BUSINESS STRATEGY 293
      • 9.3.6 SWOT ANALYSIS 294
    • 9.4 ENVIGO 295
      • 9.4.1 OVERVIEW 295
      • 9.4.2 FINANCIALS 296
      • 9.4.3 SERVICE PORTFOLIO 296
      • 9.4.4 KEY DEVELOPMENTS 298
      • 9.4.5 BUSINESS STRATEGY 299
      • 9.4.6 SWOT ANALYSIS 300
    • 9.5 EVOTEC A.G. 301
      • 9.5.1 OVERVIEW 301
      • 9.5.2 FINANCIALS 303
      • 9.5.3 SERVICE PORTFOLIO 306
      • 9.5.4 KEY DEVELOPMENTS 308
      • 9.5.5 BUSINESS STRATEGY 310
      • 9.5.6 SWOT ANALYSIS 311
    • 9.6 LABORATORY CORP. OF AMERICA HOLDINGS (LABCORP) 312
      • 9.6.1 OVERVIEW 312
      • 9.6.2 FINANCIALS 314
      • 9.6.3 SERVICE PORTFOLIO 316
      • 9.6.4 KEY DEVELOPMENTS 318
      • 9.6.5 BUSINESS STRATEGY 318
      • 9.6.6 SWOT ANALYSIS 319
    • 9.7 MERCK KGAA 320
      • 9.7.1 OVERVIEW 320
      • 9.7.2 FINANCIALS 322
      • 9.7.3 SERVICE PORTFOLIO 325
      • 9.7.4 KEY DEVELOPMENTS 325
      • 9.7.5 BUSINESS STRATEGY 325
      • 9.7.6 SWOT ANALYSIS 326
    • 9.8 MPI RESEARCH 327
      • 9.8.1 OVERVIEW 327
      • 9.8.2 FINANCIALS 328
      • 9.8.3 SERVICE PORTFOLIO 328
      • 9.8.4 KEY DEVELOPMENTS 329
      • 9.8.5 BUSINESS STRATEGY 329
      • 9.8.6 SWOT ANALYSIS 330
    • 9.9 SGS GROUP 331
      • 9.9.1 OVERVIEW 331
      • 9.9.2 FINANCIALS 333
      • 9.9.3 SERVICE PORTFOLIO 336
      • 9.9.4 KEY DEVELOPMENTS 337
      • 9.9.5 BUSINESS STRATEGY 337
      • 9.9.6 SWOT ANALYSIS 338
    • 9.10 WUXI APPTEC 339
      • 9.10.1 OVERVIEW 339
      • 9.10.2 FINANCIALS 340
      • 9.10.3 SERVICE PORTFOLIO 341
      • 9.10.4 KEY DEVELOPMENTS 342
      • 9.10.5 BUSINESS STRATEGY 342

    The study of adverse effects of chemicals and other biologic substances on living organisms is termed as toxicology. The term toxicology is broadly used in various industries such as agrochemical, pharmaceutical, medical devices, cosmetics, and others. Toxicologists are responsible for the development, implementation, and interpretation of toxicological tests to meet regulatory requirements and data quality standards (e.g., GLPs). According to IQ4I analysis, the toxicology services global market is expected to grow at high single digit CAGR to reach $14,343.0 million by 2025. Mandatory toxicology testing in various industries such as pharmaceutical, agriculture, environmental and chemical, rapid technology advancements, increased demand for crop protection are some of the driving factors for this industry. Increasing trend in outsourcing the toxicology services and increasing end stage drug failures are creating newer opportunities for the market to grow. However, opposition to animal testing in case of in vivo tests and increased funding towards drug repurposing are hindering the market to grow.
    Toxicology services global market is classified based on methods, industries, endpoint tests, and geography. Based on methods the toxicology services market can be divided into two segments i.e., in vivo, and in vitro. In silico methods have been included in the in vitro segment along with ex vivo methods. Based on industries the segment is further classified as pharmaceutical industry (discovery and preclinical), medical device industry, cosmetics, chemical industry (industrial chemicals, agrochemicals, environmental) and others (consumer goods and food). The endpoints segment can be classified as systemic toxicology, organ toxicology, dermal toxicology, neurotoxicology, ocular toxicology, genotoxicology, developmental and reproductive toxicology, carcinogenicity and ecotoxicology.
    Based on geography toxicology services global market is classified as North America, Europe, APAC and Rest of the world. North America accounts for the highest market share followed by Europe. The region is backed by huge government funding, mandatory toxicology testing regulations and streamlined toxicology guidelines which makes the volume of tests higher. Particularly in the case of pharmaceutical industry, the research for new drug candidates in on a rise taking a look at the pipeline drugs which makes these regions grow in terms of revenue and market size. However, Asian countries especially China and India are the fastest growing regions with its growing demand for toxicology services products.
    Major players in toxicology services market include Charles River Laboratories (U.S.), Labcorp (Covance) (U.S.), Envigo (U.S.), MPI Research Inc. (U.S.), Eurofins (Luxembourg), Wuxi (China), SGS (Switzerland), Merck KGaA (Bioreliance Inc.) (Germany), Evotec (Germany), Bureau Veritas (Maxxam) (France).
    The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
    • North America
    o U.S.
    o Others

    • Europe
    o Germany
    o U.K.
    o France
    o Others

    • Asia-Pacific
    o Japan
    o China
    o India
    o Others
    • Rest of the World (RoW)
    o Brazil
    o Rest of Latin America
    o Middle-East and Others

    Buy now